Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mannion

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Pediatric Rheumatology Online Journal|July 22, 2025
Disease activity at two consecutive registry visits and subsequent medication escalation for patients with juvenile idiopathic arthritis in the CARRA registryMelissa L Mannion, Monica S Aswani, K Ria Hearld, et al.
The Journal of Rheumatology|September 16, 2020
Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance RegistryMelissa L Mannion, Fenglong Xie, Daniel B Horton, et al.
American Journal of Epidemiology|September 9, 2020
Oral Glucocorticoids and Incident Treatment of Diabetes Mellitus, Hypertension, and Venous Thromboembolism in ChildrenDaniel B Horton, Fenglong Xie, Lang Chen, et al.
Pediatric Rheumatology Online Journal|September 7, 2016
Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patientsMelissa L Mannion, Fenglong Xie, John Baddley, et al.
Life (Basel, Switzerland)|February 25, 2022
A Rare STXBP2 Mutation in Severe COVID-19 and Secondary Cytokine Storm SyndromeDaniel D Reiff, Mingce Zhang, Emily A Smitherman, et al.
Arthritis Research & Therapy|September 23, 2016
The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritisTimothy Beukelman, Fenglong Xie, John W Baddley, et al.
Pediatric Rheumatology Online Journal|November 11, 2017
Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective studyMatthew L Stoll, James Aaron Grubbs, Timothy Beukelman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2024
Changes in the Workforce Characteristics of Providers Who Care for Adult Patients With Rheumatologic and Musculoskeletal Disease in the United StatesMelissa L Mannion, Fenglong Xie, John D FitzGerald, et al.
Pediatric Rheumatology Online Journal|January 26, 2018
Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: a comparative study of children with and without juvenile idiopathic arthritisMatthew L Stoll, Saurabh Guleria, Melissa L Mannion, et al.
ACR Open Rheumatology|September 16, 2025
Safety and Effectiveness of Combination Rituximab and Cyclophosphamide Therapy for Treating Pediatric Patients With Severe Manifestations of Rheumatic DiseaseEileen Rife, Daniel Reiff, John Bridges, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Pediatric Rheumatology Online Journal|July 22, 2025
Disease activity at two consecutive registry visits and subsequent medication escalation for patients with juvenile idiopathic arthritis in the CARRA registryMelissa L Mannion, Monica S Aswani, K Ria Hearld, et al.
The Journal of Rheumatology|September 16, 2020
Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance RegistryMelissa L Mannion, Fenglong Xie, Daniel B Horton, et al.
American Journal of Epidemiology|September 9, 2020
Oral Glucocorticoids and Incident Treatment of Diabetes Mellitus, Hypertension, and Venous Thromboembolism in ChildrenDaniel B Horton, Fenglong Xie, Lang Chen, et al.
Pediatric Rheumatology Online Journal|September 7, 2016
Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patientsMelissa L Mannion, Fenglong Xie, John Baddley, et al.
Life (Basel, Switzerland)|February 25, 2022
A Rare STXBP2 Mutation in Severe COVID-19 and Secondary Cytokine Storm SyndromeDaniel D Reiff, Mingce Zhang, Emily A Smitherman, et al.
Arthritis Research & Therapy|September 23, 2016
The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritisTimothy Beukelman, Fenglong Xie, John W Baddley, et al.
Pediatric Rheumatology Online Journal|November 11, 2017
Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective studyMatthew L Stoll, James Aaron Grubbs, Timothy Beukelman, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 25, 2024
Changes in the Workforce Characteristics of Providers Who Care for Adult Patients With Rheumatologic and Musculoskeletal Disease in the United StatesMelissa L Mannion, Fenglong Xie, John D FitzGerald, et al.
Pediatric Rheumatology Online Journal|January 26, 2018
Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: a comparative study of children with and without juvenile idiopathic arthritisMatthew L Stoll, Saurabh Guleria, Melissa L Mannion, et al.
ACR Open Rheumatology|September 16, 2025
Safety and Effectiveness of Combination Rituximab and Cyclophosphamide Therapy for Treating Pediatric Patients With Severe Manifestations of Rheumatic DiseaseEileen Rife, Daniel Reiff, John Bridges, et al.
Pageof 5